Kiniksa Pharmaceuticals International (KNSA) Gains from Sales and Divestitures (2018 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Gains from Sales and Divestitures of -$22,000 for Q2 2026, compared with $34,000 a year earlier.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Gains from Sales and Divestitures (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gains from Sales and Divestitures at Kiniksa Pharmaceuticals International was $128,000, up 433.3% year-over-year; for FY2025, it was $120,000, up 400.0% from FY2024.
- In prior years, Kiniksa Pharmaceuticals International's Gains from Sales and Divestitures was $24,000 in FY2024, -$179,000 in FY2023, -$33,000 in FY2022 and -$103,000 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Gains from Sales and Divestitures since Q1 2023.
- According to Business Quant data, Gains from Sales and Divestitures for the three prior quarters was $54,000 (Q1 2026), $53,000 (Q4 2025) and $43,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22,000.00 |
| Mar 31, 2026 | 54,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Mar 31, 2023 | -175,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2022 | 11,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Mar 31, 2018 | -66,000.00 |
API Access
Kiniksa Pharmaceuticals International Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();